期刊文献+

盐酸格拉司琼注射液的处方筛选及稳定性研究 被引量:2

Formula Optimization and Stability Study of Granisetron Hydrochloride Injection
下载PDF
导出
摘要 目的:制备盐酸格拉司琼注射液并考察其稳定性。方法:以外观色泽、澄明度、有关物质、含量、pH为指标,筛选处方,考察3批样品的稳定性。结果:最佳处方关键因素为pH5.0~7.0,加入辅料聚乙烯吡咯烷酮(PVP)0.2%;以该处方制备的3批样品在市售包装条件下经加速、室温留样考察,质量稳定。结论:该处方设计合理,注射液质量稳定。 OBJECTIVE: To prepare granisetron hydrochloride injection(GHI) and study its stability.METHODS: The formula of GHI was optimized with appearances and color, clarity, the related substances, contents and pH value as indexes,and the stabilities of 3 batches of samples were investigated.RESULTS:The key factors in optimized formula was the following : the pH was 5.0-7.0,and the dosage ratio of the added adjuvant - polyvinyl pyrrolidone(PVP)was 0.2% .The 3 batches of samples prepared in this formula were stable in quality in the accelerated, room temperature storage test under the condition of commercial packing.CONCLUSION:The formula is reasonable in design and the injection is stable in quality.
作者 毛红
出处 《中国药房》 CAS CSCD 北大核心 2006年第19期1462-1464,共3页 China Pharmacy
关键词 盐酸格拉司琼注射液 制备 稳定性 Granisetron hydrochloride injection Preparation Stability
  • 相关文献

参考文献2

  • 1Quercia RA,Zhang J ,Fan C,et al .Stability of granis-etron hydrochloride in an extemporaneously prepared oral liquid[J ] .Am J Health Syst Pharm, 1997, 54(12) :1 404.
  • 2Mayron D,Gennaro AR.Stability and compatibility of granisetron hydrochlorlde in i.v. solutions and oral liquids and during simulated Y- site injection with selected drugs[J ] .Am J Health Syst Pharm , 1996, 53(3) :294.

同被引文献23

  • 1陈为平,漆其光,邹红玲.格拉司琼胶囊与格拉司琼注射液治疗化疗所致的胃肠道反应疗效比较[J].广东药学,2004,14(5):52-53. 被引量:2
  • 2潘伟,陈志祥.盐酸格拉司琼注射液细菌内毒素检查法[J].中国药师,2005,8(2):166-168. 被引量:5
  • 3石庆平,桑冉.格拉司琼预防化疗呕吐的有效性和安全性Meta分析[J].中国临床药理学与治疗学,2006,11(3):332-335. 被引量:3
  • 4国家药典委员会.中国药典[s].二部.北京:中国医药科技出版社,2010.
  • 5Abang AM,Takemoto MH,Pham T, et al.Efficacy and safety of oral granisetron versus i.v. granisetron in patients underging peripheral blood progenitor cell and bone marrow transplantation[J]. Anticancer Drugs,2000, 11 (2): 137- 142.
  • 6Lindley C, Blower R Oral serotonin type3-receptor antagonists for prevention of chemotherapy-induced emesis[J]. American Journal of Health-System Pharmacy,2000, 57(18): 1685-1697.
  • 7Anastasia PJ. Effectiveness of oral 5-HT3 receptor antagonists for emetogenic chemotherapy[J]. Oncology Nursing Forum,2000, 27(3): 483-493.
  • 8Lehoczky O. Report on the antiemetic effectivity of a single lmg oral granisetron in moderately emetogenic chemotherapies of gynaecological malignancies[J]. European Journal of Gynaecological Oncology, 1998,19(5): 449-452.
  • 9Helen Dunn!ngton, Rodney Huntvr. GruiJetron Trxsdermal Patch for Treatment of Nausea in PatientJ Undergoing Cijp!atin BaJed Chemother- apy for Cervical Cancer[J]. Journal of Cancer Therapy, 2013,3(6): 1159- 1163.
  • 10Shahrbanou Keyhanian, 0 Tazikt, MM Sargvi, A Randomized Compari- son of Gran/etn Plu DexamethaJon with GraniJetro !oae for be Control of Acute Chemotherapy-Induood Erttesil and Nausog[J], Intoma- tiollal Journal of Hematology-Oncolo and Stem Cell Research, 2011,3 (2); 27-30,.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部